Company profile
ChitogenX Inc.
OTC: CHNXF · Healthcare · Biotechnology
Canadian filerHQ Kirkland, QCReports USD
#1166 of 1,422 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 24
v0.1 · 5/100 weight · pillars only
↑ disclosure history, market scale · ↓ balance-sheet leverage, Altman-Z
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$1.2M
Employees
5
as of 2026-08-26
Market cap
$627.6k
as of 2026-08-26
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$00 CAD2024
Net income-$1.2M-1.6M CAD2024
Operating income-$2.1M-2.8M CAD2024
Total assets$398.6k534.0k CAD2024
Liabilities$5.0M6.7M CAD2024
Equity-$4.6M-6.2M CAD2024
Revenue trend
FY2017 – FY2024 · USD
FY17
FY18
FY19
FY20
FY21
FY22
FY23
FY24
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is ChitogenX Inc.’s revenue?
ChitogenX Inc. booked $0 in FY2024 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
Pharmadrug Inc.——Agentix Corp.17DNKGen Biotech, Inc.——Hepion Pharmaceuticals, Inc.24D4Cable TV International, Inc.——Apptly Health Technologies Corp.——Key facts
CEOPierre Laurin
SectorHealthcare
IndustryBiotechnology
HeadquartersKirkland, QC
ExchangeOTC: CHNXF
Employees5
IPO date2020-10-06
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.